US2013210763A1PendingUtilityA1

Synergism of gos and polyfructose

59
Assignee: NUTRICIA NVPriority: May 17, 2004Filed: Jan 25, 2013Published: Aug 15, 2013
Est. expiryMay 17, 2024(expired)· nominal 20-yr term from priority
Inventors:Gelske SpeelmansMaria Johanna Adriana Petronella GoversJan KnolEric Alexander Franciscus Van Tol
A61P 37/08A61P 3/02A61P 29/00A61P 1/14A61P 21/02A61P 17/00A61P 1/00A61P 1/10A61P 1/04A61P 1/06A23L 33/125A23V 2002/00A61K 31/715A23V 2200/318A23L 7/00A61K 31/733A61K 31/01A61K 31/702A23L 29/244A23L 33/10A23L 33/40A23L 33/22A23L 5/00A23L 29/30
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to the field of prebiotics. Provided are uses for compositions comprising synergistically effective amounts of polyfructose and galactooligosaccharides (GOS).

Claims

exact text as granted — not AI-modified
1 - 15 . (canceled) 
     
     
         16 . A method of treating or preventing a condition selected from allergy, eczema and atopic diseases, the method comprising administering to a mammal in need thereof a composition comprising galactooligosaccharide and polyfructose. 
     
     
         17 . The method according to  claim 16 , wherein the ratio of galactooligosaccharide:polyfructose is 3:97 to 97:3. 
     
     
         18 . The method according to  claim 16 , wherein the ratio of galactooligosaccharide:polyfructose is 5:95 to 95:5. 
     
     
         19 . The method according to  claim 16 , wherein the ratio of galactooligosaccharide:polyfructose is 90:10 to 45:55. 
     
     
         20 . The method according to  claim 16 , wherein the galactooligosaccharide is transgalacto-oligosaccharide. 
     
     
         21 . The method according to  claim 16 , wherein the polyfructose is inulin. 
     
     
         22 . The method according to  claim 16 , wherein the galactooligosaccharide is transgalacto-oligosaccharide and the polyfructose is inulin. 
     
     
         23 . The method according to  claim 21 , wherein the inulin has an average degree of polymerization of 20 to 150. 
     
     
         24 . The method according to  claim 22 , wherein the inulin has an average degree of polymerization of 20 to 150. 
     
     
         25 . The method according to  claim 16 , wherein the composition is suitable for oral administration to an infant.

Join the waitlist — get patent alerts

Track US2013210763A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.